Tuesday, January 21, 2020 1:55:22 PM
BY Dow Jones & Company, Inc.
— 3:26 AM ET 01/21/2020
The following table shows the largest shareholders in MARKER THERAPEUTICS INC COM (MRKR) for the quarter ended December 31, 2019, listed by holding size. The list represents up to 50 of the largest holders in the company.
Note: Unless otherwise mentioned the reporting date is 12/31/2019
Institution Shares Shares % Last
Held Changed Held Report
Perceptive Advisors LLC 2,000,000 0 4.374 09/30
Aisling Capital Management LP 2,000,000 0 4.374 09/30
BlackRock Fund Advisors 1,670,347 51,725 3.653 09/30
Baker Bros. Advisors LP 1,500,000 0 3.281 09/30
The Vanguard Group Inc. 1,498,195 103,992 3.277 09/30
SSgA Funds Management Inc. 544,503 46,925 1.191 09/30
Geode Capital Management LLC 403,839 27,378 0.883 09/30
Northern Trust Investments In 328,388 205,171 0.718 09/30
Marshall Wace LLP 161,400 161,400 0.353 09/30
Morgan Stanley & Co. LLC 143,008 142,947 0.313 09/30
Hunter Associates Investment M 100,000 100,000 0.219 09/30
BlackRock Investment Managemen 96,593 2,868 0.211 09/30
ALPS Advisors Inc. 91,058 (4,092) 0.199 09/30
Citadel Advisors LLC 87,611 87,611 0.192 09/30
The Bank of New York Mellon Co 74,730 1,343 0.163 09/30
Arrowstreet Capital LP 69,650 500 0.152 09/30
Wedbush Securities Inc. (Inve 65,068 8,500 0.142 12/31
Charles Schwab Investment Mana 64,593 0 0.141 12/31
Vanguard Fiduciary Trust Co. 54,425 24,758 0.119 09/30
Susquehanna Financial Group LL 53,131 (8,004) 0.116 09/30
Bailard Inc. 51,000 10,000 0.112 09/30
Millennium Management LLC 47,093 47,093 0.103 09/30
Riggs Asset Management Co. In 46,019 0 0.101 09/30
BlackRock Advisors LLC 45,239 0 0.099 09/30
California State Teachers' Ret 41,721 0 0.091 09/30
Teachers Advisors LLC 41,407 0 0.091 09/30
State of Wisconsin Investment 40,700 40,700 0.089 09/30
FNY Capital Management LP 35,325 3,267 0.077 12/31
Parametric Portfolio Associate 32,133 32,133 0.070 09/30
Neville Rodie & Shaw Inc. 30,101 0 0.066 12/31
One68 Global Capital LLC 30,000 0 0.066 09/30
BMO Family Office LLC 28,983 28,983 0.063 09/30
Wells Fargo Bank NA (Private 27,984 15,065 0.061 09/30
TIAA-CREF Investment Managemen 27,790 0 0.061 09/30
New York State Common Retireme 27,600 0 0.060 09/30
AllianceBernstein LP 25,800 7,200 0.056 09/30
Personal Capital Advisors Corp 25,712 25,712 0.056 09/30
Ingalls & Snyder LLC 24,700 (56,900) 0.054 12/31
Virtu Financial BD LLC 23,686 23,686 0.052 09/30
UBS Securities LLC 23,177 5,115 0.051 09/30
BlackRock Financial Management 23,167 0 0.051 09/30
Edge Wealth Management LLC 22,000 20,000 0.048 09/30
RhumbLine Advisers LP 21,739 1,059 0.048 09/30
Wells Capital Management Inc. 20,405 2,097 0.045 09/30
AQR Capital Management LLC 19,608 19,608 0.043 09/30
Manulife Investment Management 19,059 148 0.042 09/30
SunAmerica Asset Management LL 17,112 (118) 0.037 09/30
BMO Asset Management Inc. 15,300 15,300 0.033 09/30
Goldman Sachs Asset Management 14,526 14,526 0.032 09/30
Group One Trading LP 13,713 6,183 0.030 09/30
13F data provided by: Factset Research Systems Inc.;
Please send questions to ownership@factset.com.
Copyright, Factset Research Systems, 2020. All Rights Reserved.
(END) Dow Jones Newswires
01-21-20 0326ET
Recent MRKR News
- Korro Announces Addition of Industry Veteran Katharine Knobil to and Resignation of David Lucchino From Its Board of Directors • GlobeNewswire Inc. • 08/28/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 08:47:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:39:13 PM
- Marker Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates • GlobeNewswire Inc. • 08/14/2024 08:30:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 11:12:59 AM
- Marker Therapeutics Awarded $2 Million Grant from NIH in Support of Phase 1 Study Investigating MT-601 in CAR-Relapsed Patients with Non-Hodgkin’s Lymphoma • GlobeNewswire Inc. • 08/12/2024 11:00:57 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/12/2024 08:05:47 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 05/17/2024 10:25:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 08:40:16 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 08:03:21 PM
- Principal Investigator from City of Hope National Medical Center Invited to Present Clinical Data from Marker Therapeutics APOLLO Study at 11th Global Summit on Hematologic Malignancies • GlobeNewswire Inc. • 04/08/2024 11:00:39 AM
- Marker Therapeutics Reports Year-End 2023 Corporate and Financial Results • GlobeNewswire Inc. • 03/25/2024 09:45:00 PM
- Marker Therapeutics to Present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference • GlobeNewswire Inc. • 03/22/2024 04:30:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/01/2024 01:02:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2024 12:58:51 PM
- Marker Therapeutics Receives Approval from United States Adopted Name (USAN) Council and International Nonproprietary Names (INN) Expert Committee for “Neldaleucel” as Nonproprietary Name for MT-601 • GlobeNewswire Inc. • 01/22/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 01:30:48 PM
- Marker Therapeutics Announces Clinical Program Updates and Pipeline Prioritization • GlobeNewswire Inc. • 01/08/2024 01:24:49 PM
- Marker Therapeutics Announces Participation in Biotech Showcase and the 19th Annual Non-Dilutive Funding Summit During “J.P. Morgan Week 2024” • GlobeNewswire Inc. • 12/21/2023 04:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2023 12:35:22 PM
- Marker Therapeutics Announces Sustained Complete Response in First Lymphoma Patient Treated with MT-601 following CAR T Relapse • GlobeNewswire Inc. • 12/11/2023 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2023 09:37:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 10:03:53 PM
- Marker Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Updates • GlobeNewswire Inc. • 11/09/2023 10:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:31:53 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM